Biomerics, the leading vertically integrated medical device contract manufacturer in the interventional device market, announced the completion of a 100,000-square-foot expansion of their operations in Brooklyn Park, Minnesota, bringing the facility to a total size of 170,000 square feet. Driven by increased demand, t…
ST Pharm successfully marked the completion of its groundbreaking ceremony, signaling a significant step forward in expanding its oligonucleotide manufacturing capacity and capabilities. The current expansion is in response to the growing demand for oligonucleotide therapeutics, including ASO, siRNA, and CRISPR, and …
Wexford Science & Technology, announced that the National Institutes of Health has signed a lease at 850 PBC and will use the space to accommodate the Phoenix Epidemiology & Clinical Research Branch of the NIH's National Institute of Diabetes and Digestive and Kidney Diseases . This innovative basic, translat…
Astellas Pharma Inc announced its intention to submit a planning application to build a new state-of-the-art facility, at an approximate cost of €330 million in Tralee, Co. Kerry. This investment by Astellas in Ireland will expand our capacity and capabilities for aseptic drug products, reinforce stable production f…
Zelis, a healthcare technology company modernizing the healthcare financial experience for all, has been named by Fortune as a 2023 Best Workplace in Health Care. Among a list of 40 large workplaces, Zelis ranked at #16 in its debut on the list. The list was compiled from more than 208,000 employee responses from var…
Access Healthcare, a premier provider of revenue cycle management, business process outsourcing, and IT services to the US healthcare sector, will recruit over 1,500 professionals in the next two months. This surge, representing approximately 6% of its workforce, is attributed to acquiring new clients and expanding s…
Eminence Biotechnology is delighted to announce that its state-of-the-art facility for the commercial production of cell culture media ("the new facility") is now fully operational. The opening aims to address the rapidly growing demand for high-quality media in the fields of vaccines, gene therapies, cell therapies,…
Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd announced that the Company has completed the integration of the acquired biosimilars business from Viatris in North America (United States and Canada) effective September 1, 2023. To further strengthen its leadership position in the global biosimilars industry an…
iXCells Biotechnologies , a cell technology company specializing in providing cell-based products and drug discovery solutions to the global academic, biotech and pharmaceutical communities, today announced completing key growth initiatives. The company relocated to new expanded facilities in San Diego, California in…
Enzene Biosciences, a subsidiary of Mumbai-based Alkem Laboratories, has announced the inauguration of its cutting-edge research and development (R&D) facility in Pune. Enzene, a leading biopharmaceutical company offering integrated Contract Development and Manufacturing (CDMO) services for Biologics, has opened …
Page 45 of 57